AstraZeneca strikes $400 million Parkinson's drug deal with Takeda

LONDON (Reuters) - AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after striking a deal for the Japanese company to co-develop an early-stage medicine for Parkinson's disease.

from Reuters: Top News http://uk.reuters.com/article/uk-astrazeneca-takeda-pharma-parkinsons-idUKKCN1B90K9?feedType=RSS&feedName=topNews